Literature DB >> 26073430

SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97.

Bruno Almeida1, Isabel A Abreu1, Carlos A Matos2, Joana S Fraga1, Sara Fernandes1, Maria G Macedo1, Ricardo Gutiérrez-Gallego3, Pedro José Barbosa Pereira1, Ana Luísa Carvalho2, Sandra Macedo-Ribeiro4.   

Abstract

BACKGROUND: Machado-Joseph Disease (MJD), a form of dominantly inherited ataxia belonging to the group of polyQ expansion neurodegenerative disorders, occurs when a threshold value for the number of glutamines in Ataxin-3 (Atx3) polyglutamine region is exceeded. As a result of its modular multidomain architecture, Atx3 is known to engage in multiple macromolecular interactions, which might be unbalanced when the polyQ tract is expanded, culminating in the aggregation and formation of intracellular inclusions, a unifying fingerprint of this group of neurodegenerative disorders. Since aggregation is specific to certain brain regions, localization-dependent posttranslational modifications that differentially affect Atx3 might also contribute for MJD.
METHODS: We combined in vitro and cellular approaches to address SUMOylation in the brain-predominant Atx3 isoform and assessed the impact of this posttranslational modification on Atx3 self-assembly and interaction with its native partner, p97.
RESULTS: We demonstrate that Atx3 is SUMOylated at K356 both in vitro and in cells, which contributes for decreased formation of amyloid fibrils and for increased affinity towards p97. CONCLUSIONS AND GENERAL SIGNIFICANCE: These findings highlight the role of SUMOylation as a regulator of Atx3 function, with implications on Atx3 protein interaction network and self-assembly, with potential impact for further understanding the molecular mechanisms underlying MJD pathogenesis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid; Polyglutamine; Posttranslational modification; Protein aggregation; Surface plasmon resonance

Year:  2015        PMID: 26073430     DOI: 10.1016/j.bbadis.2015.06.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Interaction between the AAA+ ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding.

Authors:  Maya V Rao; Dewight R Williams; Simon Cocklin; Patrick J Loll
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

2.  2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition.

Authors:  Soojay Banerjee; Alberto Bartesaghi; Alan Merk; Prashant Rao; Stacie L Bulfer; Yongzhao Yan; Neal Green; Barbara Mroczkowski; R Jeffrey Neitz; Peter Wipf; Veronica Falconieri; Raymond J Deshaies; Jacqueline L S Milne; Donna Huryn; Michelle Arkin; Sriram Subramaniam
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

3.  Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.

Authors:  Xiao-Jing Li; Yuan-Yuan Zhang; Yu-Hua Fu; Hao Zhang; He-Xuan Li; Quan-Fu Li; Hai-Ling Li; Ren-Ke Tan; Chen-Xiao Jiang; Wei Jiang; Zeng-Xia Li; Cheng Luo; Bo-Xun Lu; Yong-Jun Dang
Journal:  Acta Pharmacol Sin       Date:  2021-01-25       Impact factor: 7.169

Review 4.  The Interplay of Cofactor Interactions and Post-translational Modifications in the Regulation of the AAA+ ATPase p97.

Authors:  Petra Hänzelmann; Hermann Schindelin
Journal:  Front Mol Biosci       Date:  2017-04-13

Review 5.  Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases.

Authors:  Fabio Sambataro; Maria Pennuto
Journal:  Front Mol Neurosci       Date:  2017-03-31       Impact factor: 5.639

Review 6.  Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.

Authors:  Yu-Shuan Chen; Zhen-Xiang Hong; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

7.  Neurodegenerative phosphoprotein signaling landscape in models of SCA3.

Authors:  Anna S Sowa; Taissia G Popova; Tina Harmuth; Jonasz J Weber; Priscila Pereira Sena; Jana Schmidt; Jeannette Hübener-Schmid; Thorsten Schmidt
Journal:  Mol Brain       Date:  2021-03-19       Impact factor: 4.041

Review 8.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

9.  VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease.

Authors:  Xing Guo; XiaoYan Sun; Di Hu; Ya-Juan Wang; Hisashi Fujioka; Rajan Vyas; Sudha Chakrapani; Amit Umesh Joshi; Yu Luo; Daria Mochly-Rosen; Xin Qi
Journal:  Nat Commun       Date:  2016-08-26       Impact factor: 14.919

Review 10.  Roles of Post-translational Modifications in Spinocerebellar Ataxias.

Authors:  Linlin Wan; Keqin Xu; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.